These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 15151456)

  • 1. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolic risk during antipsychotic treatment in patients with schizophrenia].
    Rzewuska M
    Psychiatr Pol; 2007; 41(4):457-72. PubMed ID: 18046977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which comes first: atypical antipsychotic treatment or cardiometabolic risk?
    Stahl SM; Mignon L; Meyer JM
    Acta Psychiatr Scand; 2009 Mar; 119(3):171-9. PubMed ID: 19178394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cardiovascular disease and sudden death in schizophrenia.
    Davidson M
    J Clin Psychiatry; 2002; 63 Suppl 9():5-11. PubMed ID: 12088174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic risk during antipsychotic treatment.
    Newcomer JW
    Clin Ther; 2004 Dec; 26(12):1936-46. PubMed ID: 15823759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of schizophrenia with obesity, metabolic, and endocrinological disorders.
    Monteleone P; Martiadis V; Maj M
    Psychiatr Clin North Am; 2009 Dec; 32(4):775-94. PubMed ID: 19944883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.
    Newcomer JW
    J Clin Psychiatry; 2007; 68 Suppl 1():20-7. PubMed ID: 17286524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schizophrenia and obesity: impact of antipsychotic medications.
    Wirshing DA
    J Clin Psychiatry; 2004; 65 Suppl 18():13-26. PubMed ID: 15600381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic syndrome and schizophrenia.
    Meyer JM; Stahl SM
    Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious cardiovascular events and mortality among patients with schizophrenia.
    Enger C; Weatherby L; Reynolds RF; Glasser DB; Walker AM
    J Nerv Ment Dis; 2004 Jan; 192(1):19-27. PubMed ID: 14718772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schizophrenia and comorbid metabolic disorders.
    Henderson DC
    J Clin Psychiatry; 2005; 66 Suppl 6():11-20. PubMed ID: 16107179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular aspects of antipsychotics.
    Raedler TJ
    Curr Opin Psychiatry; 2010 Nov; 23(6):574-81. PubMed ID: 20838345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical implications of weight gain in schizophrenia.
    Kurzthaler I; Fleischhacker WW
    J Clin Psychiatry; 2001; 62 Suppl 7():32-7. PubMed ID: 11346194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Obesity in adults with serious and persistent mental illness: a review of postulated mechanisms and current interventions.
    Megna JL; Schwartz TL; Siddiqui UA; Herrera Rojas M
    Ann Clin Psychiatry; 2011 May; 23(2):131-40. PubMed ID: 21547274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response to the position of the "Biological Psychiatry" Working Group of the Federal Directors Conference--Association of Executive Physicians of Psychiatry and Psychotherapy Clinics (BDK) e.V].
    Aderhold V
    Psychiatr Prax; 2009 Mar; 36(2):94-5. PubMed ID: 19358097
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical risk in patients with bipolar disorder and schizophrenia.
    Newcomer JW
    J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic risk factors in drug-naive patients with first-episode psychosis.
    Verma SK; Subramaniam M; Liew A; Poon LY
    J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.